# A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients

> **NCT01964547** · PHASE4 · COMPLETED · sponsor: **Jazz Pharmaceuticals** · enrollment: 121 (actual)

## Conditions studied

- Multiple Sclerosis
- Spasticity

## Interventions

- **DRUG:** Sativex
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01964547
- **Lead sponsor:** Jazz Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2023-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01964547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01964547, "A Randomized Study of Sativex on Cognitive Function and Mood: Multiple Sclerosis Patients". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01964547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*